Projekt

Zurück zur Übersicht

Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome - the AUTO-REST Study

Titel Englisch Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome - the AUTO-REST Study
Gesuchsteller/in Manconi Mauro
Nummer 144007
Förderungsinstrument Projektförderung (Abt. I-III)
Forschungseinrichtung Ospedale Regionale di Lugano
Hochschule Ente Ospedaliero Cantonale - EOC
Hauptdisziplin Nervenheilkunde, Psychiatrie
Beginn/Ende 01.06.2013 - 31.12.2015
Bewilligter Betrag 276'500.00
Alle Daten anzeigen

Alle Disziplinen (2)

Disziplin
Nervenheilkunde, Psychiatrie
Herz- und Kreislauferkrankungen

Keywords (5)

Restless Legs Syndrome; Periodic leg movements during sleep; Autonomic nervous system; Cardiovascular disorders; Animal model

Lay Summary (Deutsch)

Lead
Das Restless legs Syndrom (RLS, Syndrom der unruhigen Beine) ist eine der häufigsten neurologischen Erkrankungen und grosse, epidemiologische Studien haben übereinstimmend ein erhöhtes Risiko für Herz-Kreislauferkrankungen bei Patienten mit RLS gezeigt. Eine der möglichen Mechanismen sind die wiederholten, nächtlichen Aktivierungen des sympathischen, autonomen Nervensystems, die im Rahmen von periodischen Beinbewegungen während des Schlafes (PLMS) bei RLS auftreten.
Lay summary

Inhalt und Ziel des Forschungsprojekts

Unser übergeordnetes Ziel ist es, die Rolle des autonomen Nervensystems in Bezug auf die Pathophysiologie des RLS und das erhöhte Risiko für Herz-Kreislauferkrankungen zu untersuchen. Dazu werden wir Patienten mit RLS und auch gesunde Kontrollpersonen im Hinblick auf (i) autonome Funktionen sowohl am Tage wie in der Nacht und (ii) sensitive Marker eines erhöhten kardiovaskulären Risikos untersuchen. Wir werden auch erforschen, ob eine 4-wöchige medikamentöse Therapie des RLS und der PLMS einen Effekt auf die autonomen Funktionen hat. Darüber hinaus werden wir in einem pharmakolgisches Tiermodell für RLS die Rolle des autonomen Nervensystems bei RLS weiter charakterisieren.

Wissenschaftlicher und gesellschaftlicher Kontext des Forschungsprojekts

Unsere Arbeit wird neue und wichtige Erkenntnisse generieren über die Rolle von PLMS und des autonomen Nervensystems im Bezug auf das kardiovaskuläre Risiko bei RLS. Insbesondere werden die Ergebnisse zu der Frage beitragen, ob eine pharmakologische Behandlung von RLS und PLMS auch das das kardiovaskuläre Risiko vermindert. Da PLMS auch bei vielen Personen ohne RLS auftreten, insbesondere bei älteren Personen, haben die Erkenntnisse über die Rolle der PLMS weitreichende Implikationen.

Direktlink auf Lay Summary Letzte Aktualisierung: 21.01.2013

Verantw. Gesuchsteller/in und weitere Gesuchstellende

Mitarbeitende

Publikationen

Publikation
A Data-Driven Analysis of the Rules Defining Bilateral Leg Movements during sleep
(2016), A Data-Driven Analysis of the Rules Defining Bilateral Leg Movements during sleep, in Sleep, 39(2), 413-421.
An Evidence-based Analysis of the Association between Periodic Leg during Sleep and Arousal in Restless Legs Syndrome
(2015), An Evidence-based Analysis of the Association between Periodic Leg during Sleep and Arousal in Restless Legs Syndrome, in Sleep, 38(6), 919-924.
Physiological time structure of the tibialis anterior motor activity during sleep in mice, rats and humans.
(2015), Physiological time structure of the tibialis anterior motor activity during sleep in mice, rats and humans., in Journal of Sleep Research, 24(6), 695-701.
Putting the periodicity back into the periodic leg movement index: an alternative data-driven algorithm for the computation of this index during sleep and wakefulness
(2015), Putting the periodicity back into the periodic leg movement index: an alternative data-driven algorithm for the computation of this index during sleep and wakefulness, in Sleep Medicine, 16, 1229-1235.
Diagnostic accuracy of the standard and alternative periodic leg movement during sleep indices for restless legs syndrome
, Diagnostic accuracy of the standard and alternative periodic leg movement during sleep indices for restless legs syndrome, in Sleep Medicine.

Zusammenarbeit

Gruppe / Person Land
Formen der Zusammenarbeit
Agnese Salvadè, Experimental Laboratory (NSI, EOC), Neurocenter of Southern Switzerland, Bellinzona Schweiz (Europa)
- vertiefter/weiterführender Austausch von Ansätzen, Methoden oder Resultaten
- Publikation
Stephen L. Leib, Neuroinfectious Diseases Laboratory, University of Bern Schweiz (Europa)
- vertiefter/weiterführender Austausch von Ansätzen, Methoden oder Resultaten
- Forschungsinfrastrukturen
Stefan Clemens, Department of Physiology, Brody School of Medicine, East Carolina University Vereinigte Staaten von Amerika (Nordamerika)
- vertiefter/weiterführender Austausch von Ansätzen, Methoden oder Resultaten
Stefano Muzzarelli, Cardiocentro, Lugano Schweiz (Europa)
- vertiefter/weiterführender Austausch von Ansätzen, Methoden oder Resultaten
- Forschungsinfrastrukturen
Francesca Baracchi, Departement Klinische Forschung, University of Bern Schweiz (Europa)
- vertiefter/weiterführender Austausch von Ansätzen, Methoden oder Resultaten
- Publikation
Stephany Fulda, Neurocenter of Southern Switzerland, Lugano Schweiz (Europa)
- vertiefter/weiterführender Austausch von Ansätzen, Methoden oder Resultaten
- Forschungsinfrastrukturen
Johannes Mathis, Department of Neurology, Inselspital, Bern University Hospital & University of Bern Schweiz (Europa)
- vertiefter/weiterführender Austausch von Ansätzen, Methoden oder Resultaten
- Forschungsinfrastrukturen
- Austausch von Mitarbeitern
Carlo Cereda, Neurocenter of Southern Switzerland, Lugano Schweiz (Europa)
- Forschungsinfrastrukturen

Kommunikation mit der Öffentlichkeit

Kommunikation Titel Medien Ort Jahr
Medienarbeit: Printmedien, Online-Medien The AutoREST STudy Deutschschweiz 2014

Auszeichnungen

Titel Jahr
The study helped our center to be recognized as the first Excellence Center of Restless legs syndrome in Switzerland, and the second in Europe. The certification is given by the International RLS Foundation 2016

Abstract

Background: Restless legs syndrome (RLS) is one of the most frequent neurological disorders, a sleep-related movement disorder, affecting 3 to 10% of the general population in various degrees of severity. The majority of RLS patients present with insomnia, and around 90% of them with periodic leg movements during sleep (PLMS). PLMS are repetitive, stereotyped leg jerks which arise from sleep. Many hundreds of such leg movements may occur during a single night. In addition to its severe effects on sensory and motor functions, large-scale epidemiological studies have consistently identified RLS as an independent risk factor for cardiovascular disease. The candidate mechanisms associated with this autonomic dysfunction involve repetitive, nocturnal sympathetic system activations associated with PLMS in RLS. The critical question is whether PLMS are the cause, the consequence, or a correlate of nocturnal sympathetic hyperactivation in RLS. Several lines of evidence including the spinal dopaminergic hypothesis of RLS place the autonomic system at the core of RLS, yielding the question whether RLS is in fact an autonomic disorder. We will address this question by combininga translational approach which will combine a case control study with a double-blind treatment trial in patients with RLS and a basic research project focussed on creating an animal model for RLS. Results of these projects are expected to answer the question whether there is a generalized autonomic dysfunction in RLS, how this relates to the specific cardiovascular risk profile of patients, and whether treatment of RLS affects autonomic function and cardiovascular risk. The animal experiments will be performed to directly explore the link between RLS and autonomic dysfunction. Objectives: 1) to characterise autonomic functioning and cardiovascular risk in patients with RLS and to explore whether autonomic function is related to other markers of cardiovascular risk in these patients; 2) to investigate the effects of treatment of RLS and PLMS on autonomic function and selected markers of cardiovascular risk; 3) to establish a pharmacological rodent model for RLS and periodic limb movements during sleep (PLMS) to decipher the underlying pathophysiology of RLS and PLMS and directly to test the primary involvement of the autonomic system in RLS.Experimental design/Methods: In a prospective case-control study 50 patients with RLS and 50 age- and sex-matched controls will be included. Autonomic function (such as heart rate variability, blood pressure, tilt table test performance), cardiovascular risk markers and polysomnography will be assessed in all subjects. Subsequently, patients with RLS will participate in a double-blind, randomised treatment study comparing the effect of 4 week treatment with a previously-established dopamine agonist versus placebo on autonomic function and the above-mentioned markers of cardiovascular risk. In addition, we will establish a pharmacological animal model of RLS that will enable us to test the assumption that autonomic dysfunction is critically involved in the pathophysiology of RLS. Expected Value of the proposed Project: This project will answer the question whether RLS/PLMS is associated with autonomic dysfunction that increases cardiovascular risk, and if its treatment normalizes these autonomic abnormalities which will contribute towards feasible prevention strategies of cardiovascular diseases in RLS patients. Moreover, this project will establish the first animal model for RLS in order to improve our knowledge on the pathophysiology of RLS and particularly the role of the autonomic system in this disease. Since effective treatments are now available for RLS and PLMS the expected results of this study will have important implications not the least of which is whether treating RLS symptoms and PLMS will reduce cardiovascular risk in RLS.
-